Screener
Pasithea Therapeutics KTTA Q4 2025 Annual earnings
Reported March 30, 2026 · After market close
EPS-$0.89Miss by $0.71
Revenue estimate$100.0K
EPS estimate-$0.18
Next report
Date not yet announcedVersus estimates
Diluted EPS
Q2 2026-$0.16In lineQ1 2026-$0.12Beat by $0.33
Q4 2025-$0.89Miss by $0.71
Q4 2026-$0.18In lineQ3 2025-$0.41Q2 2025-$0.66FAQ
- When did Pasithea Therapeutics report Q4 2025 earnings?
- Pasithea Therapeutics (KTTA) reported Q4 2025 earnings on March 30, 2026 after market close.
- What were Pasithea Therapeutics's Q4 2025 revenue and EPS?
- Pasithea Therapeutics reported eps of $-0.89 for Q4 2025.
- Did Pasithea Therapeutics beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.18 by $0.71.
- How did Pasithea Therapeutics's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 63.1% from $-2.41.
- Where can I find Pasithea Therapeutics's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001213900-26-036434) directly on SEC EDGAR. The filing index links above go to sec.gov.
